Constipation News and Research

Latest Constipation News and Research

Controlling diarrhoea and constipation in autistic children without using antibiotics

Scientists checking bacteria which live in the intestines of autistic children may have found a way to control gut problems, such as diarrhoea or constipation, without using antibiotics

8 Sep 2004

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Encysive Pharmaceuticals today announced the presentation of data from a clinical study of Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European Society of Cardiology Annual Congress in Munich.

31 Aug 2004

Pfizer drug effectively treats overactive bladder symptoms

Women with mixed incontinence, a combination of overactive bladder and stress incontinence, reported a greater treatment benefit for overactive bladder symptoms from DETROL® LA (tolterodine tartrate extended release capsules) than placebo, according to new study results published in the August issue of Urology.

21 Aug 2004

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.

3 Aug 2004

First successful gene therapy that mimics the action of calcium channel blockers

Their findings - published in the latest edition of Circulation Research, online July 8 - may lead to a gene therapy alternative to calcium channel blockers and their sometimes severe side effects, but also further interest in the development of gene therapies unique - as in this case - to one particular organ.

10 Jul 2004

New educational campaign on celiac disease

The Children's Digestive Health and Nutrition Foundation (CDHNF) with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) today announced the launch of a new educational campaign on celiac disease

30 Jun 2004

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).

29 Jun 2004

Genetically engineered thyroid stimulating hormone destroys tissue that often remains after thyroidectomy

A new approach to therapy can avoid most of the debilitating effects of preparing for critical, postsurgical treatment for patients with thyroid cancer, according to an international study led by researchers from Johns Hopkins and the University of Pisa.

16 Jun 2004

Identification of early ovarian cancer symptoms may have important clinical implications

Symptoms experienced by women that are more severe or frequent than expected and of recent occurrence warrant further diagnostic investigation because they are more likely to be associated with both benign (non-cancerous) and malignant (cancerous) ovarian masses

14 Jun 2004

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

Solvay Pharmaceuticals unveiled this week results from a six-month study of both male and female patients and from a subgroup analysis of males with Irritable Bowel Syndrome with Diarrhea predominance (IBS-D).

24 May 2004

FDA approves new drug for bone marrow disease

The Food and Drug Administration (FDA) today announced the approval of Vidaza (azacitidine) injection, the first effective treatment for patients with Myelodysplastic Syndrome (MDS). The product was given Fast Track Status and a priority review.

19 May 2004

Comparison study shows low-carbohydrate, high-protein diet loses more weight than low-fat, low-cholesterol, low-calorie diet

People who followed a low-carbohydrate, high-protein diet lost more weight than people on a low-fat, low-cholesterol, low-calorie diet during a six-month comparison study at Duke University Medical Center. However, the researchers caution that people with medical conditions such as diabetes and high blood pressure should not start the diet without close medical supervision.

19 May 2004

Physicians perceive overactive bladder as a normal part of aging when in fact it is a treatable medical condition

Nearly half of people with symptoms of overactive bladder had to initiate multiple conversations with their doctor before receiving a diagnosis or treatment, according to a national survey of more than 500 people with symptoms of overactive bladder. Furthermore, only 15 percent of those surveyed said their doctors had ever initiated a discussion about overactive bladder symptoms.

12 May 2004

Wyeth gets FDA approval for a novel protein device that enhances bone healing

Wyeth have announced that the FDA has approved rhBMP-2/ACS (recombinant human Bone Morphogenetic Protein-2/Absorbable Collagen Sponge), a novel protein device that enhances bone healing, for use in the treatment of acute, open tibia shaft fractures in adults.

3 May 2004

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

The Food and Drug Administration (FDA) today announced the addition of new risk information to the health professional labeling for Zelnorm (tegaserod maleate). Zelnorm is a prescription medication for the short-term treatment of women with irritable bowel syndrome (IBS) whose primary bowel symptom is constipation.

30 Apr 2004

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Two studies presented today at the American Academy of Neurology (AAN) 56th Annual Meeting show that pregabalin, when used as an add-on treatment for epilepsy, does not affect male reproductive function or interfere with the effectiveness of oral contraceptives.

29 Apr 2004

$Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year$

Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year

Results of a new analysis found that, without treatment, one out of 13 postmenopausal osteoporotic women who were initially fracture-free were likely to experience a spinal fracture within one year.

28 Apr 2004

FDA mandates approval for all pancreatic enzyme replacements

The Cystic Fibrosis Foundation has announced its support of the Food and Drug Administration's (FDA) requirement that manufacturers of pancreatic enzyme replacements obtain FDA approval for their products within the next four years.

27 Apr 2004

ULTRACET® Effective And Well Tolerated For Post-Surgical Pain

A new study published in the latest edition of a leading medical journal has shown that treatment with ULTRACET® (37.5 mg tramadol hydrochloride/325 mg acetaminophen tablets) demonstrates similar efficacy and better tolerability than TYLENOL® with Codeine No. 3 when each is compared to placebo.

5 Apr 2004

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Merck/Schering-Plough Pharmaceuticals today announced the regulatory approval of INEGYTM (ezetimibe/simvastatin) in Germany for the treatment of elevated cholesterol (hypercholesterolemia). INEGY is the first product to reduce low-density lipoprotein cholesterol (LDL-C or ‘bad’ cholesterol), along with diet and exercise, through dual inhibition by inhibiting cholesterol production in the liver and absorption in the intestine. The approval of INEGY in Germany represents the first approval in Europe for ezetimibe/simvastatin tablets and the first step in seeking marketing approval throughout the European Union (EU) under the EU’s mutual recognition procedure.

4 Apr 2004

Constipation News and Research

Latest Constipation News and Research

Controlling diarrhoea and constipation in autistic children without using antibiotics

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Pfizer drug effectively treats overactive bladder symptoms

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

First successful gene therapy that mimics the action of calcium channel blockers

New educational campaign on celiac disease

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Genetically engineered thyroid stimulating hormone destroys tissue that often remains after thyroidectomy

Identification of early ovarian cancer symptoms may have important clinical implications

Significant symptom relief reported in clinical trial patients with irritable bowel syndrome

FDA approves new drug for bone marrow disease

Comparison study shows low-carbohydrate, high-protein diet loses more weight than low-fat, low-cholesterol, low-calorie diet

Physicians perceive overactive bladder as a normal part of aging when in fact it is a treatable medical condition

Wyeth gets FDA approval for a novel protein device that enhances bone healing

FDA updates Zelnorm labeling a treatment of women with irritable bowel syndrome

Studies show pregabalin does not affect male reproductivity or interfere with oral contraceptives

Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year

FDA mandates approval for all pancreatic enzyme replacements

ULTRACET® Effective And Well Tolerated For Post-Surgical Pain

First Approval in Europe of Ezetimibe/Simvastatin for treatment of elevated cholesterol

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Constipation News and Research

Latest Constipation News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in